日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Integrative Meta-Analysis Identifies Epithelial-Mesenchymal Transition Gene Signatures as Key Determinants of Ovarian Cancer Progression and Treatment Outcome

综合荟萃分析发现上皮-间质转化基因特征是卵巢癌进展和治疗结果的关键决定因素

Cassandri, Matteo; Pontecorvi, Paola; Cece, Fabrizio; Camero, Simona; Mele, Giada; Romano, Enrico; Ceccarelli, Simona; Rizzi, Roberto; Marampon, Francesco; Angeloni, Antonio; Marchese, Cinzia; Megiorni, Francesca

From bench to bedside: combining HDAC inhibitors with standard therapies in rhabdomyosarcoma treatment

从实验室到临床:将 HDAC 抑制剂与标准疗法联合用于横纹肌肉瘤治疗

Macrì, Elisa; Attili, Marika; Locatelli, Franco; Marampon, Francesco; Pomella, Silvia

Clinical outcomes of three-fraction versus five-fraction stereotactic radiosurgery for resected brain metastases

切除脑转移瘤的立体定向放射外科手术三分次与五分次治疗的临床结果

Minniti, Giuseppe; Tini, Paolo; Navarria, Piera; Raza, Giorgio; Pepa, Giuseppe Maria Della; Chiesa, Silvia; De Felice, Francesca; Zaccaro, Lucy; Capone, Luca; Tomaciello, Miriam; Lanzetta, Gaetano; Giraffa, Martina; Russo, Ivana; Marampon, Francesco; Bruno, Antonio; Paolini, Sergio

Neddylation inhibition induces DNA double-strand breaks, hampering tumor growth in vivo, and promotes radiosensitivity in PAX3-FOXO1 rhabdomyosarcoma.

Neddylation抑制可诱导DNA双链断裂,从而阻碍体内肿瘤生长,并促进PAX3-FOXO1横纹肌肉瘤的放射敏感性。

Aiello Francesca Antonella, D'Archivio Lucrezia, Attili Marika, Ferraro Erika, Macrì Elisa, Mazzocchi Riccardo, Cassandri Matteo, Pomella Silvia, Tocco Valeria, Pezzullo Marco, De Stefanis Cristiano, Codenotti Silvia, Barillari Giovanni, Marchese Cinzia, Fanzani Alessandro, Megiorni Francesca, Shipley Janet, Yohe Marielle, Gatz Susanne A, Houghton Peter J, Cenci Giovanni, Quintarelli Concetta, Locatelli Franco, Marampon Francesco, De Angelis Biagio, Rota Rossella

Synthetic inhibition of SREBP2 and the mevalonate pathway blocks rhabdomyosarcoma tumor growth in vitro and in vivo and promotes chemosensitization

合成抑制SREBP2和甲羟戊酸途径可阻断横纹肌肉瘤肿瘤在体外和体内的生长,并促进化疗增敏。

Codenotti, Silvia; Asperti, Michela; Poli, Maura; Lorenzi, Luisa; Pietrantoni, Alberto; Cassandri, Matteo; Marampon, Francesco; Fanzani, Alessandro

Disrupting resistance: novel therapeutic approaches to combat multidrug resistance in fusion-negative rhabdomyosarcoma

突破耐药性:对抗融合阴性横纹肌肉瘤多药耐药性的新型治疗方法

Codenotti, Silvia; Marampon, Francesco; Megiorni, Francesca; Cattaneo, Carlo Guglielmo; Gastaldello, Stefano; Pozzo, Enrico; Sampaolesi, Maurilio; Rota, Rossella; Keller, Charles; Fanzani, Alessandro

Deciphering the Transcriptional Metabolic Profile of Adipose-Derived Stem Cells During Osteogenic Differentiation and Epigenetic Drug Treatment.

解读成骨分化和表观遗传药物治疗过程中脂肪来源干细胞的转录代谢谱

Gerini Giulia, Traversa Alice, Cece Fabrizio, Cassandri Matteo, Pontecorvi Paola, Camero Simona, Nannini Giulia, Romano Enrico, Marampon Francesco, Venneri Mary Anna, Ceccarelli Simona, Angeloni Antonio, Amedei Amedeo, Marchese Cinzia, Megiorni Francesca

[Retracted] Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models

【已撤稿】PXD101(贝利司他)对雄激素依赖型和雄激素非依赖型前列腺癌模型的不同影响

Gravina, Giovanni Luca; Marampon, Francesco; Giusti, Ilaria; Carosa, Eleonora; Di Sante, Stefania; Ricevuto, Enrico; Dolo, Vincenza; Tombolini, Vincenzo; Jannini, Emmanuele A; Festuccia, Claudio

RETRACTED: Gravina et al. The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models. Cancers 2019, 11, 359

撤稿:Gravina 等人,《小分子 Ephrin 受体抑制剂 GLPG1790 可降低癌症干细胞的更新能力,并在临床前胶质母细胞瘤模型中显示出抗肿瘤功效》,Cancers 2019, 11, 359

Gravina, Giovanni Luca; Mancini, Andrea; Colapietro, Alessandro; Monache, Simona Delle; Sferra, Roberta; Vitale, Flora; Cristiano, Loredana; Martellucci, Stefano; Marampon, Francesco; Mattei, Vincenzo; Beirinckx, Filip; Pujuguet, Philippe; Saniere, Laurent; Lorenzon, Giocondo; Aar, Ellen van der; Festuccia, Claudio

RETRACTED: Gravina et al. The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models. Cancers 2019, 11, 1604

撤稿:Gravina 等人。《脑穿透性双重 TORC1/TORC2 抑制剂 RES529 在临床前小鼠模型中表现出抗胶质瘤活性并增强抗血管生成化合物的治疗效果》。Cancers 2019, 11, 1604

Gravina, Giovanni Luca; Mancini, Andrea; Colapietro, Alessandro; Delle Monache, Simona; Sferra, Roberta; Pompili, Simona; Vitale, Flora; Martellucci, Stefano; Marampon, Francesco; Mattei, Vincenzo; Biordi, Leda; Sherris, David; Festuccia, Claudio